Articles related to Optometry

Patients taking semaglutide for diabetes were more than four times more likely to develop NAION compared to those on other diabetes medications, while those using it for obesity had a seven-fold increased risk.

Autonomous AI at the point of care significantly increases diabetic retinopathy screening rates among young patients, addressing access gaps in underserved communities and offering a practical solution to improve patient outcomes.

Understand the subtle yet impactful symptoms of early-stage cataracts, including changes in color perception and glare sensitivity, to better guide your patients towards timely diagnosis and treatment.

In a significant advance for pediatric diabetes care, the introduction of the AI-based IDx-DR has doubled screening rates for diabetic retinopathy, underscoring the potential of technology to democratize healthcare access and eliminate racial bias in diagnostic processes.

A groundbreaking study in The Lancet Neurology reports that 94% of patients with posterior cortical atrophy also have Alzheimer’s disease pathology, stressing the need for heightened awareness among clinicians for earlier diagnosis and intervention.

With the approval of Vabysmo, it’s a new era in the treatment of macular edema following RVO. This therapy has demonstrated comparable vision gains to aflibercept in clinical trials, offering a promising alternative for your patients.